Bruce Lyday
Senior Dengue Virus Advisor, Co-Founder
Bruce is the inventor of record of the ArboPrime technology patent. Bruce is responsible for current and future scientific development at PrimeVax.
Prior to joining PrimeVax, Bruce conducted academic research in the fields of Oncology, Immunology, and Virology for over 20 years. While attending California State University, Long Beach, he conceived the use of the dengue virus as a cancer immunotherapy adjuvant.
Bruce holds a Post-Graduate Certificate in Clinical Research from the University of California, Irvine, and worked as the Clinical Research Manager for Pacific Coast Hematology/Oncology Medical Group in Fountain Valley, California.